CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.

University of Pennsylvania is suing three leading insulin makers and companies that negotiate drug price deals for insurance plans, accusing them of a scheme to drive up prices of a medication that ...

" PA is an independent, nonpartisan, and nonprofit newsroom producing investigative and public-service journalism that holds ...

The perk is worth up to $31,412.40 a year for lawmakers choosing a top-tier family plan, but not everyone takes it.

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

In this opinion piece, former Democratic National Committee chairperson Howard Dean urges Democrats in Congress to help lower ...

The big health insurers Moody's rates now face shrinking profit margins at the Medicaid plans they manage for state ...

The California Public Employees’ Retirement System (CalPERS) has a new pharmacy benefits contract with CVS Caremark, the ...

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it overcharged Medicare for prescription drugs.